daratumumab,pf-06863135
janssen,pfizer
['magnetismm-5', 'multiplemyeloma', 'tps8074', 'pfizer']
see more at #asco22 about the ongoing ph 3 magnetismm-5 study evaluating the safety &amp; efficacy of a bcma-cd3 bispecific antibody as monotherapy or in combination with an anti-cd38-based regimen in patients with r/r #multiplemyeloma tps8074 
Dedicated to communicating emerging science from Pfizer Oncology. Please see our community guidelines: https://t.co/MU3blmItSZ